Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol.

Sec. Vaccines and Molecular Therapeutics

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1697855

Correction: Protection against N. gonorrhoeae induced by OMV-based Meningococcal Vaccines are associated with cross-species directed humoral and cellular immune responses

Provisionally accepted
weiyan zhuweiyan zhu1Andreea WaltmannAndreea Waltmann1Marguerite B LittleMarguerite B Little2Kristie L ConnollyKristie L Connolly3Kathryn A MatthiasKathryn A Matthias4Keena S ThomasKeena S Thomas5Mary GrayMary Gray5Aleksandra Elzbieta SikoraAleksandra Elzbieta Sikora6Alison CrissAlison Criss5Margaret BashMargaret Bash4Andrew N. MacintyreAndrew N. Macintyre7Ann JerseAnn Jerse3Joseph Alex DuncanJoseph Alex Duncan1*
  • 1Medicine/Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
  • 2Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
  • 3Uniformed Services University of the Health Sciences Department of Microbiology & Immunology, Bethesda, United States
  • 4US Food and Drug Administration, Silver Spring, United States
  • 5University of Virginia, Charlottesville, United States
  • 6Oregon State University, Corvallis, United States
  • 7Duke University School of Medicine, Durham, United States

This article is a correction to:

  1. Protection against N. gonorrhoeae induced by OMV-based Meningococcal Vaccines are associated with cross-species directed humoral and cellular immune responses

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

Keywords: Neisseria gonnorhoeae, Vaccine, Neisseria meningitidis, Outer membrane vesicle (OMV), correlates of protection

Received: 02 Sep 2025; Accepted: 03 Sep 2025.

Copyright: © 2025 zhu, Waltmann, Little, Connolly, Matthias, Thomas, Gray, Sikora, Criss, Bash, Macintyre, Jerse and Duncan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Joseph Alex Duncan, Medicine/Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, 27599-7030, NC, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material